Pediatric Neuroblastoma Treatment Market by Treatment Type [Chemotherapy, Immunotherapy, Targeted Therapy, and Radiation Therapy], Risk Group [Low Risk, Intermediate-Risk, and High Risk], End User [Hospital and Cancer Specialty Center] - Global Outlook & Forecast 2021-2031

  • Report Code : gpr824099
  • Pages : 174
  • Published On : Aug 2022
  • Industry : Healthcare and Pharmaceuticals
  • Format :

Choose License Type

Single User License: US$ 4,750
Multi User License: US$ 5,680
Corporate User License: US$ 7,750
The Pediatric Neuroblastoma Treatment Market is predicted to reach US$ 1,863.1 million by 2031 from US$ 759.5 million in 2020, and to grow at a CAGR of ~8.5% between the forecast period 2021 to 2031.

The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2021 to 2031. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2020. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.

Major segmentation covered in this report is as follows:

Treatment Type [Chemotherapy, Immunotherapy, Targeted Therapy, and Radiation Therapy], Risk Group [Low Risk, Intermediate-Risk, and High Risk], End User [Hospital and Cancer Specialty Center]


By Region

North America, Europe, Asia Pacific, and the Rest of the World

Major market players covered in this study are

Bayer AG, Pfizer Inc., Apeiron Biologics AG., United Therapeutics Corporation, Y-mAbs Therapeutics, Inc., Cellectar Biosciences, Inc., Clarity Pharmaceuticals, Provectus Biopharmaceuticals, Inc., and Scorpion Therapeutics, among others.


1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2020
2. Base Year - 2021
3. Forecasted Years - 2022 to 2031
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Pediatric Neuroblastoma Treatment - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Pediatric Neuroblastoma Treatment - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Pediatric Neuroblastoma Treatment - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Pediatric Neuroblastoma Treatment - ANALYSIS & FORECAST, BY REGION
North America Pediatric Neuroblastoma Treatment
1. North America Pediatric Neuroblastoma Treatment , by Country
1. US
2. Canada
1. North America Pediatric Neuroblastoma Treatment , by Product
2. North America Pediatric Neuroblastoma Treatment , by Type
3. North America Pediatric Neuroblastoma Treatment , by Gender
4. North America Pediatric Neuroblastoma Treatment , by Sales Channel
3. Europe Pediatric Neuroblastoma Treatment
1. Europe Pediatric Neuroblastoma Treatment , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Pediatric Neuroblastoma Treatment , by Product
3. Europe Pediatric Neuroblastoma Treatment , by Type
4. Europe Pediatric Neuroblastoma Treatment , by Gender
5. Europe Pediatric Neuroblastoma Treatment , by Sales Channel
4. Asia Pacific Pediatric Neuroblastoma Treatment
1. Asia Pacific Pediatric Neuroblastoma Treatment , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Pediatric Neuroblastoma Treatment , by product
3. Asia Pacific Pediatric Neuroblastoma Treatment , by Type
4. Asia Pacific Pediatric Neuroblastoma Treatment , by Gender
5. Asia Pacific Pediatric Neuroblastoma Treatment , by Sales Channel
5. Rest of the World Pediatric Neuroblastoma Treatment
1. Rest of the World Pediatric Neuroblastoma Treatment , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Pediatric Neuroblastoma Treatment , by Product
3. Rest of the World Pediatric Neuroblastoma Treatment , by Type
4. Rest of the World Pediatric Neuroblastoma Treatment , by Gender
5. Rest of the World Pediatric Neuroblastoma Treatment , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 26

Treatment Management System Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Treatment Management System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufac...

Hospital Treatment Fee Evaluation Services Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Hospital Treatment Fee Evaluation Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lan...

Ion Exchange Technology For Water Treatment Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Ion Exchange Technology For Water Treatment Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive la...

Comprehensive Wastewater Treatment Service Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Comprehensive Wastewater Treatment Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lan...

Cardiac Stem Cell Treatment Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Cardiac Stem Cell Treatment Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufac...

Alcohol Treatment Services Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Alcohol Treatment Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufact...

Substance Abuse Treatment Billing Services Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Substance Abuse Treatment Billing Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lan...

Waste Gas Treatment System Solutions Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Waste Gas Treatment System Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape...

Asia Pacific Peritoneal Dialysis Market Size, Share, Trends & Analysis by Product (Peritoneal Solution, Peritoneal Dialysis Catheters, Implantation Systems, Other Accessories), by Treatment Type (Automated Peritoneal Dialysis (APD), Continuous Ambulatory Peritoneal Dialysis (CAPD)), by End-User (Hospitals, Homecare Settings, Dialysis Centers) and Region, with Forecasts from 2024 to 2034....

Market Overview The Asia Pacific Peritoneal Dialysis Market is projected to experience substantial growth from 2024 to 2034, driven by the rising prevalence of end-stage renal disease (ESRD), advancements in peritoneal dialysis (PD) technologies, and an increasing shift towards home-bas...

Europe Peritoneal Dialysis Market Size, Share, Trends & Analysis by Product (Peritoneal Solution, Peritoneal Dialysis Catheters, Implantation Systems, Other Accessories), by Treatment Type (Automated Peritoneal Dialysis (APD), Continuous Ambulatory Peritoneal Dialysis (CAPD)), by End-User (Hospitals, Homecare Settings, Dialysis Centers) and Region, with Forecasts from 2024 to 2034....

Market Overview The Europe Peritoneal Dialysis Market is projected to experience robust growth from 2024 to 2034, driven by the rising prevalence of chronic kidney disease (CKD) and the increasing adoption of peritoneal dialysis (PD) as a preferred treatment modality. The market is anti...